Mixed results with drug delivery to prevent in-stent restenosis
This article was originally published in Clinica
Executive Summary
Low molecular-weight (LMW) heparin delivered via catheter after coronary stent implantation does not prevent subsequent restenosis, according to the largest trial to date of the treatment. However, a smaller Polish study claims the technique can cut restenosis rates by a half.